Clinical Trials Logo

Financial Stress clinical trials

View clinical trials related to Financial Stress.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06288399 Enrolling by invitation - Obesity Clinical Trials

Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational Study

Start date: December 21, 2023
Phase:
Study type: Observational

The aim of this study is to assess the annual prevalence of ORCs among adult people with obesity in the real-world clinical setting across the Gulf region. In addition, the study will describe the annual HCRU and associated costs of obesity and ORCs, describe the demographics and clinical characteristics of adult people with obesity, as well as estimate the annual incidence and point prevalence of the ORCs among adult people with obesity.

NCT ID: NCT05871125 Enrolling by invitation - Breast Cancer Clinical Trials

Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to identify the recommended financial reimbursement amount for women with breast cancer enrolled in a clinical trial. The main questions it aims to answer are: 1. What is the recommended financial reimbursement amount in trial-enrolled women with breast cancer experiencing financial toxicity? 2. What do patients think about receiving a reimbursement for trial-incurred expenses? Participants will receive a monthly reimbursement to compensate for their trial-incurred expenses in cohorts, which will de-escalate for the next participant cohort if patients find the reimbursement dose suitable (negative financial toxicity screen, reimbursement dose deemed acceptable/appropriate). Researchers will also use qualitative interviews to explore patient perceptions of the trial reimbursements.